1st R&D Training Day in Biopharmaceuticals and Medical Devices

Event details
Date | 22.03.2017 |
Hour | 08:30 › 17:30 |
Speaker |
Brigitte Happ, PhD Regulatory Affairs, Happ-Consulting, Merck, Serono, Giba-Geigy Kostas Kaloulis, PhD Business Development & Entrepreneurship, EPFL, LifeCare Partners, ReMedys, NsGene, Merck, Apoxis Mariagrazia di Marco, PhD Medical Devices and Clinical Research, HUG, Nanobiotix, Guerbet Tiziana Mattioni, PhD Precinical & Clinical Development, Consulting, Genenta, Merck, Serono Sonia Poli, PhD Biopharma R&D, Poli Consulting, Dimerix, Addex, Roche Elisabeth Svanberg, PhD-MD Clinical and Product Development, Ixaltis, Janssen, J&J, BMS |
Location | |
Category | Internal trainings |
Are you interested on how to translate research into society useful applications?
Then you are invited by the School of Life Sciences and the Applied Innovation Mechanism (AIM) at the VP Innovation to this 1-day course.
6 Industry Experts will discuss, and give you an overview, on how to Pave the Path from Researchto Product Development.
Limited Places!
TO REGISTER PLEASE FILL IN THIS DOODLE: http://doodle.com/poll/2y5sbewhz8nzm7p7
Goal: This course aims to introduce key topics of drug and medical devices development and medical devices
Learning objectives: At the end of the course, the participant will be able to understand:
· the main principles of clinical development for Drugs and Devices
· the border between a drug and a medical device
· how to translate a project from bench to bed
· the importance of Good Clinical Practice
· the importance of project oversight
· the role of regulatory affairs in drug development
· the importance health authority engagement
· key elements required for partnering and licensing
Learning methods: Lectures, case studies
About AIM: AIM’s ambition is to Provide; funding, R&D Industry expertise and network, business development/Planning support and industrial network, entrepreneurship in residence, to help validating technologies and identifying potential industry partners, or other “exits”, to advance these technologies to the marketplace.
AIM’s primary goal is to advance technologies to the inflection point where additional funding from industry and/or technology transfer is feasible or achieved.
AIM’s vision is to evolve, in alignment with all relevant stake holders, into the 1st Innovation Incubator supporting all schools at EPFL.
AIM is an initiative designed to accommodate all tools and expertise into supporting projects of varying magnitude, and area.
AIM pilot is currently supporting several projects at the School of Life Sciences.
Practical information
- General public
- Free
Organizer
- Applied Innovation Mechanism (AIM) at the VP Innovation, EPFL